Inactive Instrument

Insiders Cancer Genetics, Inc.

Equities

CGIX

US13739U2033

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

Cancer Genetics, Inc. has Changed its Name to Vyant Bio, Inc	21-03-30	CI
Cancer Genetics, Inc. Appoints Roland J. Carrillo as the Vice President of Business Development	21-03-18	CI
Cancer Genetics : Johns Hopkins University - Stephen Baylin Named Fellow of the American Association for the Advancement of Science	20-11-25	AQ
Cancer Genetics, Inc. Announces Executive Changes	20-11-20	CI
Cancer Genetics, Inc. Announces Resignation of Dr. Raju S.K. Chaganti	20-09-30	CI
Cancer Genetics, Inc. Announces Board Resignations	19-07-19	CI
Cancer Genetics, Inc. Appoints William Finger as Executive Vice President, Precision Medicine and Biopharma Solutions	19-01-09	CI
Cancer Genetics, Inc. Announces Executive Changes	18-11-14	CI
Rita Shaknovich, Chief Medical Officer and Group Medical Director of Cancer Genetics, Inc, to Resign from Her Position with Effective from September 12, 2018	18-08-13	CI
Cancer Genetics, Inc. Appoints Michael McCartney as Chief Commercial Officer	18-06-12	CI
Cancer Genetics, Inc Appoints John A. Roberts as Chief Executive Officer and President	18-05-01	CI
Cancer Genetics, Inc. Announces Management Changes	18-02-05	CI
Cancer Genetics, Inc. Appoints Thomas F. Widmann to its Board of Directors	17-11-27	CI
Cancer Genetics : Named One of the Top 10 Drug Discovery & Development Solution Providers by Panel of Industry Experts at Pharma Tech Outlook	17-10-31	PU
Cancer Genetics Named One of the Top 10 Drug Discovery & Development Solution Providers by Panel of Industry Experts at Pharma Tech Outlook	17-10-31	GL
Cancer Genetics, Inc. Appoints Igor Gitelman as New Principal Accounting Officer	17-02-16	CI
Cancer Genetics, Inc. Announces Consolidation in Administrative and Operational Support Functions; Commits to Reduction in the Workforce; Announces Executive Changes	17-01-06	CI
Cancer Genetics, Inc. Announces Resignation of Jane Houldsworth El Naggar as Vice President of Research and Development	16-09-16	CI
Cancer Genetics, Inc. Appoints John Jay Roberts as COO and Executive Vice President of Finance, Effective on July 11, 2016	16-06-27	CI
Cancer Genetics, Inc. Appoints Rita Shaknovich as Medical Director and Vice President of Hematopathology Services	15-07-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Cancer Genetics, Inc.

Equities

CGIX

US13739U2033

Insiders

Filters